Long-term follow-up study for people treated for cancer
Part of Cancer clinical trials.
This study looks at how people who have finished treatment for cancer are doing over the long term. It uses information from a cancer center registry to understand survivorship and outcomes after surgery and/or other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You finished treatment for a cancer (malignant tumor) during your stay at Fudan University Shanghai Cancer Center.
- Your diagnosis was confirmed before surgery or during the operation.
- Your treatment may have included surgery, radiation (radiotherapy), chemotherapy, immunotherapy, or a mix.
- You must have been treated as an inpatient during the hospitalization (not just evaluated).
- You were treated for cancer, not a non-cancer (non-malignant) condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people diagnosed with breast cancer to learn more about the disease and treatment. It may help improve future care.
This study looks at young people (40 or younger at diagnosis) with solid tumors in China. It aims to collect real-world information about their treatments and outcomes to find patterns that could help improve care.
This study looks at how people with testicular cancer are doing after finishing treatment. It mainly focuses on follow-up visits (surveillance) and whether you are in remission, which can help doctors understand and improve post-treatment care.
This study offers a program to help people who have completed their main treatment for early-stage breast or prostate cancer. It focuses on follow-up and support during survivorship, and you are still eligible if you are on certain maintenance therapies like hormone therapy.
This study is looking back at the medical records of people with early-stage non-small cell lung cancer who had surgery or radiation therapy between 2018 and 2019. The goal is to understand how patients were diagnosed and treated, which may help improve care for others in the future.
This trial studies a standard follow-up plan to help you stay on track after radiation treatment for lung cancers or certain related conditions. It may help your care team monitor symptoms and outcomes in a consistent way.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.